THERAtRAME

Foundation date

23/05/2022

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

THERAtRAME is a new biotech start-up which aims to revolutionize drug discovery by exploring new target areas to develop innovative cancer therapies. Our pioneering approach exploits the new target space of tRNA epitranscriptiomics. Powered by a proprietary AI-driven drug discovery platform, THERAtRAME is developing novel first-in-class drug candidates to create better treatments for cancer patients.

Upcoming events

Latest news

  • Japan welcomes companies, startups and knowledge institutions from Flanders

    Friday December 2nd 2022

  • FIT stimulates market diversification with renewed subsidy

    Thursday December 1st 2022

  • Biotalys creates Scientific Advisory Committee with leading experts

    Thursday December 1st 2022